Kratom

The honest answer is more interesting than either side wants it to be. Fatal outcomes from kratom alone are rare. Nearly all recorded deaths involved combinations.

Health Canada lists potential for abuse and dependence. The published evidence supports that, with important nuance about how the most-quoted survey figure is generated.

This is the kratom risk least likely to appear on a vendor website and arguably the most practically important, especially for anyone already taking prescription medication.

Health Canada lists liver toxicity among its stated risks. It is real, it is uncommon, and it usually reverses when caught early. Here is what the case literature actually documents.

Most vendors avoid this subject entirely. Here is what the published literature and Health Canada actually document, including the parts that are uncomfortable for a company that sells this material.

A comparison written by a Canadian vendor, so read it with that in mind. Here is where domestic genuinely wins, and where US vendors are genuinely better.

The short answer is no, and the reason is worth understanding: kratom regulation in Canada operates federally. But there are two places provincial rules still matter.

Every vendor in this category uses the phrase and almost none explain it. It is not a disclaimer for show. It is what keeps the product outside a regulatory framework it is not authorized under.

Health Canada has said it works with the Canada Border Services Agency to stop kratom entering the country. Here is what that means for a parcel crossing the border.

Health Canada has a clear, published position on kratom. This is what it actually says, quoted from its own advisories rather than paraphrased.